Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $862.68M in the quarter ending September 30, 2026, with 9.96% growth. This brings the company's total for the last twelve months to $3.20B, up 8.88% year-over-year. In the year 2025, Amneal Pharmaceuticals had annual revenue of $3.02B with 8.05% growth. That makes Amneal Pharmaceuticals the 3,658th largest company in the world by revenue and 1,015th in the United States.

• Revenue (ttm): $3.20B
• Revenue Growth: +8.88%
• P/S Ratio: 2.20
• Revenue / Employee: $367,324
• Employees: 8,700
• Market Cap: 7.01B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Affordable Medicines Net 1.75B 57.8%
• AvKARE Net 744.73M 24.7%
• Specialty Net 528.51M 17.5%

Fiscal year ended Dec 31, 2025 See the full Amneal Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.02B	224.80M	8.05%
Dec 31, 2024	2.79B	400.35M	16.73%
Dec 31, 2023	2.39B	181.30M	8.20%
Dec 31, 2022	2.21B	118.64M	5.67%
Dec 31, 2021	2.09B	101.15M	5.08%
Dec 31, 2020	1.99B	366.15M	22.51%
Dec 31, 2019	1.63B	-36.62M	-2.20%
Dec 31, 2018	1.66B	629.34M	60.88%
Dec 31, 2017	1.03B	15.43M	1.52%
Dec 31, 2016	1.02B	151.95M	17.54%
Dec 31, 2015	866.28M	-	-

Data Source: Fiscal.ai Last updated: Nov 3, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error